H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.7% of adults in West Palm Beach have diagnosed diabetes — 1.7 points above the U.S. 12% figure. Census population 117,415. Florida Medicare wound biologics: First Coast Service Options (JN). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed West Palm Beach clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a West Palm Beach storefront.
Pressure Ulcer Treatment Solutions in West Palm Beach, FL for clinics & physicians. Advanced pressure ulce… Compliance support & pricing — contact Hawk Medical.
16.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 13.7% of adults in West Palm Beach have diagnosed diabetes — 1.7 points above the U.S. 12% figure. Population 117,415. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JN documentation are ready before the first application of pressure ulcer treatment.
National Pressure Ulcer Treatment Solutions notes (how the product actually works)16.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 117,415 residents will still mix those payers. CDC PLACES (2023, crude) estimates 13.7% of adults in West Palm Beach have diagnosed diabetes — 1.7 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 13.7% of adults in West Palm Beach have diagnosed diabetes — 1.7 points above the U.S. 12% figure. Adult arthritis here is 26.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for West Palm Beach.
CDC PLACES (2023, crude prevalence) estimates 13.7% of adults — 1.7 points above the U.S. 12% figure. Obesity is 29.1%; arthritis is 26.1%. That is place-level BRFSS modeling, not a clinic census and not a West Palm Beach trial.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
No. First Coast Service Options writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in West Palm Beach.
Bring specialty, monthly wound volume, and whether you bill JN FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 13.7% diabetes and 26.1% arthritis for West Palm Beach — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in West Palm Beach, FL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for West Palm Beach is JN geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for West Palm Beach — 1.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Florida Part B wound biologics follow this contractor (siblings: no other states). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in West Palm Beach. Useful for joint-program math; still needs a diagnosis and privileging.
No West Palm Beach storefront. Joe Bradley is an active practice owner. pressure ulcer treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.